Pharmaceuticals (4,499)

Browse by Company

Acacia Diversified Holdings, Inc. (4)
Acasti Pharma Inc. (2)
ACELRX PHARMACEUTICALS INC (25)
Acer Therapeutics Inc. (15)
Aclaris Therapeutics, Inc. (19)
Acreage Holdings, Inc. (34)
ACURA PHARMACEUTICALS, INC (11)
Adamis Pharmaceuticals Corp (21)
ADIAL PHARMACEUTICALS, INC. (29)
AERIE PHARMACEUTICALS INC (9)
Aerpio Pharmaceuticals, Inc. (6)
AGILE THERAPEUTICS INC (20)
Akorn (20)
ALIMERA SCIENCES INC (22)
Allergan, plc (3)
Amag Pharmaceuticals (33)
AmeriCann, Inc. (8)
Amneal Pharmaceuticals, Inc. (25)
Amphastar Pharma (10)
Ampio Pharmaceuticals, Inc. (18)
ANI Pharma Inc (13)
Applied BioSciences Corp. (13)
APRICUS BIOSCIENCES, INC. (32)
Aquestive Therapeutics, Inc. (10)
ARADIGM CORP (2)
ARTELO BIOSCIENCES, INC. (15)
ARVINAS, INC. (19)
Assertio Therapeutics, Inc (21)
AVADEL PHARMACEUTICALS PLC (12)
AVENUE THERAPEUTICS, INC. (4)
AXIM BIOTECHNOLOGIES, INC. (2)
Axsome Therapeutics, Inc. (21)
Bakhu Holdings, Corp. (12)
Barrel Energy Inc. (1)
Baudax Bio, Inc. (42)
Bausch Health Companies Inc. (15)
Bespoke Extracts, Inc. (32)
BIODELIVERY SCIENCES INTERNATIONAL INC (15)
BioPharmX Corp (30)
BODY & MIND INC. (33)
Boston Therapeutics, Inc. (5)
Bristol-Myers Squibb (67)
Canbiola, Inc. (45)
Cannabics Pharmaceuticals Inc. (22)
CANNAPHARMARX, INC. (12)
CANNAPOWDER, INC. (2)
Canopy Growth Corp (5)
Cara Therapeutics, Inc. (12)
CARDAX, INC. (29)
CASSAVA SCIENCES INC (8)
Catalent Inc (34)
Celexus, Inc (7)
Cerecor Inc. (35)
CHIASMA, INC (18)
CHINA PHARMA HOLDINGS, INC. (5)
Citius Pharmaceuticals, Inc. (36)
Clearside Biomedical, Inc. (21)
CLS Holdings USA, Inc. (17)
CNS Pharmaceuticals, Inc. (17)
Cocrystal Pharma, Inc. (16)
COLLEGIUM PHARMACEUTICAL, INC (18)
ContraVir Pharmaceuticals, Inc. (20)
Corcept Therapeutics Incorporated (15)
CorMedix Inc. (16)
Cronos Group Inc. (25)
CUMBERLAND PHARMACEUTICALS INC (16)
Cure Pharmaceutical Holding Corp. (29)
CymaBay Therapeutics, Inc. (5)
DURECT CORP (9)
Elanco Animal Health Inc (28)
ELITE PHARMACEUTICALS INC (16)
Eloxx Pharmaceuticals, Inc. (8)
Endo International plc (37)
EPHS HOLDINGS, INC. (2)
Eton Pharmaceuticals, Inc. (14)
Evofem Biosciences, Inc. (27)
Evoke Pharma Inc (11)
Evolus, Inc. (14)
Exactus, Inc. (36)
EYEGATE PHARMACEUTICALS INC (21)
EYENOVIA, INC. (21)
EyePoint Pharmaceuticals, Inc. (21)
FRONTIER OILFIELD SERVICES INC (5)
Fulcrum Therapeutics, Inc. (29)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (24)
GREEN HYGIENICS HOLDINGS INC. (22)
Green Thumb Industries Inc. (1)
GW PHARMACEUTICALS PLC (6)
HARROW HEALTH, INC. (17)
Horizon Pharma plc (37)
Hoth Therapeutics, Inc. (37)
IMAGING3 INC (30)
IMARA Inc. (21)
INNOVATE BIOPHARMACEUTICALS, INC. (39)
Innoviva, Inc. (6)
IntelGenx Technologies Corp. (13)
Intersect ENT, Inc. (19)
Intra-Cellular Therapies, Inc. (15)
Item 9 Labs Corp. (4)
Iterum Therapeutics plc (29)
Jaguar Health, Inc. (90)
Jazz Pharmaceuticals plc (45)
Johnson & Johnson (6)
Kala Pharmaceuticals, Inc. (10)
Kaleido Biosciences, Inc. (29)
Kannalife Inc (22)
KEMPHARM, INC (51)
Lannett Company, Inc. (22)
Level Brands, Inc. (31)
Lexaria Bioscience Corp. (37)
Lilly (Eli) & Co. (30)
Lipocine Inc. (10)
Liquidia Corp (20)
Liquidia Technologies Inc (14)
Lyra Therapeutics, Inc. (15)
Mallinckrodt (16)
Marijuana Co of America, Inc. (6)
MARINUS PHARMACEUTICALS INC (11)
MedGen, Inc. (3)
Medicine Man Technologies, Inc. (41)
Menlo Therapeutics Inc. (28)
Merck (13)
MICROCHANNEL TECHNOLOGIES CORP (90)
Milestone Pharmaceuticals Inc. (28)
MJ Holdings, Inc. (42)
Mylan N.V. (39)
MYnd Analytics, Inc. (39)
MyoKardia Inc (16)
Nabriva Therapeutics plc (20)
NEKTAR THERAPEUTICS (9)
Neos Therapeutics, Inc. (36)
NewBridge Global Ventures, Inc. (31)
NEXIEN BIOPHARMA, INC. (2)
NGM BIOPHARMACEUTICALS INC (16)
Notis Global, Inc. (18)
NovaBay Pharmaceuticals, Inc. (42)
Novan, Inc. (33)
Novus Therapeutics, Inc. (11)
OCULAR THERAPEUTIX, INC (22)
Odonate Therapeutics, Inc. (5)
OMEROS CORP (17)
Onconova Therapeutics, Inc. (36)
OPIANT PHARMACEUTICALS, INC. (9)
OptiNose, Inc. (12)
ORAMED PHARMACEUTICALS INC. (20)
Osmotica Pharmaceuticals plc (13)
OTONOMY, INC. (5)
Pacira Pharmaceuticals, Inc. (13)
Paratek Pharmaceuticals, Inc. (25)
Perrigo (34)
Pfizer (22)
Pharmagreen Biotech Inc. (10)
Phathom Pharmaceuticals, Inc. (34)
Phibro Animal Health Corporation (8)
Pivot Pharmaceuticals Inc. (2)
PLAYERS NETWORK (9)
PLIANT THERAPEUTICS, INC. (20)
PLx Pharma Inc. (15)
Prestige Brands Holdings Inc (4)
Processa Pharmaceuticals, Inc. (32)
ProPhase Labs, Inc. (12)
PROTECT PHARMACEUTICAL Corp (1)
PROTEO INC (6)
PROVECTUS BIOPHARMACEUTICALS, INC. (7)
Provention Bio, Inc. (15)
Pulmatrix, Inc. (27)
QUANTA INC (25)
REATA PHARMACEUTICALS INC (25)
Recro Pharma, Inc. (27)
RELMADA THERAPEUTICS, INC. (27)
RespireRx Pharmaceuticals Inc. (101)
resTORbio, Inc. (77)
Revance Therapeutics, Inc. (30)
Royalty Pharma plc (45)
Satsuma Pharmaceuticals, Inc. (29)
Scopus BioPharma Inc. (27)
scPharmaceuticals Inc. (8)
SCYNEXIS INC (20)
SenesTech, Inc. (32)
SIGA TECHNOLOGIES INC (15)
Sonoma Pharmaceuticals, Inc. (21)
Stem Holdings, Inc. (13)
Strongbridge Biopharma plc (12)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
Supernus Pharmaceuticals, Inc. (10)
Target Group Inc. (17)
Teligent, Inc. (30)
Tenzing Acquisition Corp. (34)
Terra Tech Corp. (76)
TETRAPHASE PHARMACEUTICALS INC (38)
TEVA PHARMACEUTICAL INDUSTRIES LTD (20)
Textmunication Holdings, Inc. (24)
TFF Pharmaceuticals, Inc. (27)
The Medicines Company (6)
TherapeuticsMD, Inc. (25)
Theravance Biopharma, Inc. (14)
Tilray, Inc. (37)
TITAN PHARMACEUTICALS INC (41)
Trevi Therapeutics, Inc. (24)
Tricida, Inc. (19)
Trulieve Cannabis Corp. (7)
United Cannabis Corp (2)
Urovant Sciences Ltd. (26)
Verrica Pharmaceuticals Inc. (13)
Vitality Biopharma, Inc. (5)
VIVUS INC (24)
Wave Life Sciences Ltd. (15)
WEED, INC. (2)
Wize Pharma, Inc. (30)
XERIS PHARMACEUTICALS INC (19)
Zoetis (8)
ZOGENIX, INC. (14)
Zomedica Pharmaceuticals Corp. (38)
Zynerba Pharmaceuticals, Inc. (7)

Browse by Contract Category

Recent Contracts

Purchase Agreement (Bespoke Extracts, Inc., Filed With SEC on February 24, 2021)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Novan, Inc., Filed With SEC on February 24, 2021)
License Agreement, dated April 16, 1999, by and among Saul Brusilow, M.D., Brusilow Enterprises, Inc. and Horizon Therapeutics, LLC (as successor in interest to Medicis... (Horizon Pharma plc, Filed With SEC on February 24, 2021)
Settlement Agreement and First Amendment to License Agreement, dated August 21, 2007, by and among Saul Brusilow, M.D., Brusilow Enterprises, Inc., and Horizon Therapeutics, LLC... (Horizon Pharma plc, Filed With SEC on February 24, 2021)
License Agreement, dated August 12, 1998, by and among Mountain View Pharmaceuticals, Inc., Duke University and Horizon Therapeutics Ireland DAC (as successor in interest to... (Horizon Pharma plc, Filed With SEC on February 24, 2021)
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Royalty Pharma plc, Filed With SEC on February 24, 2021)
Bausch Health Companies Inc. Further Amended and Restated 2014 Omnibus Incentive Plan, effective as of April 28, 2020 (the "Amended and Restated 2014 Omnibus Incentive Plan") (Bausch Health Companies Inc., Filed With SEC on February 24, 2021)
Form of Spinoff Bonus Program Letter Agreement dated November 2, 2020 (Bausch Health Companies Inc., Filed With SEC on February 24, 2021)
Director Nomination and Appointment Agreement by and among Bausch Health Companies Inc., Carl C. Icahn and the persons and entities listed therein, dated February 23, 2021 (Bausch Health Companies Inc., Filed With SEC on February 24, 2021)
Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2021) (Jazz Pharmaceuticals plc, Filed With SEC on February 23, 2021)